In response to rising demand for weight loss medications, WeightWatchers has launched a low-cost alternative to ...
Sima Sistani helped push the company into the GLP-1 drug space with the $106 million acquisition of Sequence.
CARRY RISK. WEIGHT WATCHERS SAYS IT WILL NOW OFFER ELIGIBLE MEMBERS COMPOUNDED SEMAGLUTIDE AS PART OF ITS HOLISTIC ...
James Corden has opened up about his experience using Ozempic for weight loss. The actor, 46, has been incredibly open about ...
WeightWatchers CEO Sima Sistani abruptly stepped down Friday after a two-year stint that included a controversial embrace of weight-loss drugs like Ozempic and Wegovy. Sistani pushed the 61-year ...
Under Sistani, the 61-year-old company bought a telehealth platform that connected patients with doctors who can prescribe weight-loss and diabetes drugs, including Ozempic and Wegovy ...